Q-linea AB (publ) (QLINEA) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Q-linea Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.117 -- 00:00:06.262 Hello, and thank you everyone for joining during the summer here for Kylenia's second 00:00:06.262 -- 00:00:11.186 quarter report. You have Stuart Gander, the CEO and President speaking, and I'm joined 00:00:11.186 -- 00:00:16.310 by our new CFO, Annika Blondo-Henriksen, who will come on later to speak to our 00:00:16.310 -- 00:00:17.912 financials. 00:00:17.912 -- 00:00:23.605 The usual disclaimer here, which we'll take as read and understood going forward. 00:00:23.605 -- 00:00:27.147 And our agenda tracks to our previous quarterly readouts here. 00:00:27.147 -- 00:00:31.590 I'll spend a little bit of time talking to the commercial update in the market and how 00:00:31.590 -- 00:00:35.553 we see things unfolding with a focus on the US market. 00:00:35.553 -- 00:00:40.416 Then we'll speak to the outlook through the year, some of the big things happening and 00:00:40.416 -- 00:00:46.319 what our operational priorities are before I turn it over to Annika to talk to our financial 00:00:46.319 -- 00:00:52.282 performance through the quarter and obviously come back around to questions and answers. 00:00:52.495 -- 00:00:57.278 All right, so for those who only have a few minutes joining us today, the key messages 00:00:57.278 -- 00:01:00.120 that I would like you to take home are as follows. 00:01:00.120 -- 00:01:03.442 We did ship out five ASTAR instruments during the quarter. 00:01:03.442 -- 00:01:08.805 I'll talk to the update there on how that translates into activities on the ground, contracting 00:01:08.805 -- 00:01:14.189 and test pull-through as we go forward. We did, as many of you will know, 00:01:14.189 -- 00:01:19.312 get approval from the FDA for our expanded menu, which 00:01:19.312 -- 00:01:24.396 now is definitively the l...